Compare VanEck Uranium & Nuclear ETF (NLR) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Uranium & Nuclear ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? VanEck Uranium & Nuclear ETF trades at $103.5 (market cap $3.61B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: VanEck Uranium & Nuclear ETF is the larger of the two by market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, VanEck Uranium & Nuclear ETF nearer its low. Which is the better fit depends on your goals.
| NLR | SLS | |
|---|---|---|
Market Cap | $3.61B | $2.28B |
Volume | 696,289 | 3,128,960 |
Sector | Sector/Thematic | Health |
52-Week High | $164.37 | $15.46 |
52-Week Low | $102.38 | $1.39 |
Typical Hold Time | 7 Days | — |
Enterprise Value | — | $2.15B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About VanEck Uranium & Nuclear ETF
VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.
Read more on NLR →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
